Cited by 59Erythropoietin and Anemia TreatmentSchizophrenia research and treatmentNeural and Behavioral Psychology Studies

Differential effects of erythropoietin on neural and cognitive measures of executive function 3 and 7 days post-administration

Miskowiak, Kamilla, Inkster, Becky, O’Sullivan, Ursula, Selvaraj, Sudhakar, Goodwin, Guy M., Harmer, Catherine J.·2008·Experimental Brain Research

Abstract

Erythropoietin (Epo) has neuroprotective and neurotrophic effects and improves cognitive function in animal models of neurodegenerative and neuropsychiatric illness. In humans, weekly Epo administration over 3 months improves cognitive function in schizophrenia. The neural underpinnings and time-course of this effect of Epo are currently unknown. It is also unclear whether the cognitive improvement reflects direct neurobiological actions or is secondary to hematological effects. We therefore assessed the actions of single administration of Epo (40,000 IU) vs. saline to healthy volunteers on cognitive and neural measures of executive function using a verbal fluency task and N-back working memory (WM) paradigm during functional magnetic resonance imaging (fMRI) on day 3 and 7 after administration in two separate cohorts of subjects. Epo modulated neuronal response in a fronto-parietal network during WM performance at both time points; on day 3 after administration, activation was increased in left-hemisphere frontal and cingulate cortex and reduced in the right parietal cortex; in contrast, neural response was enhanced in a right-lateralized fronto-parietal network and reduced in left-side regions 1 week post-administration. In addition, Epo-treated volunteers displayed improved verbal fluency performance 1 week post-administration. These effects occurred in the absence of changes in hematological measures suggesting that they reflect direct neurobiological actions of Epo. The findings are consistent with enduring effects of Epo on neurotrophic signaling and induction of neurochemical changes over time in neural networks typically affected in neuropsychiatric illness. The present study supports the notion that Epo may have clinical applications in the treatment of psychiatric disorder characterized by cognitive dysfunction.

Integrity signals

Registry

Crossref · 10.1007/s00221-007-1102-1

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In healthy volunteers, erythropoietin modulated neuronal activity in a frontoparietal network during working memory and improved executive function (verbal fluency) 1 week after a single high-dose administration of 40,000 IU.

    “In healthy volunteers, EPO modulated neuronal activity in a frontoparietal network during working memory and improved executive function (i.e. verbal fluency) 1 week after a single high-dose administration (40,000 IU) [96].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Miskowiak, K., Inkster, B., O’Sullivan, U., Selvaraj, S., Goodwin, G. M., & Harmer, C. J.
Affiliations
  • University of Oxford (GB)
  • Warneford Hospital (GB)
Corresponding author
Miskowiak, Kamilla
Venue
Experimental Brain Research
Published
2007-09-08
Volume
184
Issue
3
Pages
313-321
ISSN
  • 0014-4819 (ISSN-L)
  • 1432-1106
OpenAlex
W2018591234
Cited by
59
References
37
Citations by year
2026: 1 · 2024: 2 · 2023: 4 · 2022: 4 · 2021: 2 · 2020: 3 · 2019: 3 · 2018: 6 · 2017: 2 · 2016: 3 · 2015: 4 · 2014: 2 · 2013: 4 · 2012: 2
FWCI
3.17
Type
journal article
Language
en
Open access
closed
Locations
  • Experimental Brain Research (publishedVersion)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Topics
  • Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
Keywords
erythropoietin, executive function, working memory, verbal fluency, frontoparietal network, hemispheric lateralization, cingulate cortex, parietal cortex, neurotrophic signaling, cognitive impairment, neuropsychiatric disorders, healthy volunteers
MeSH terms
Adult, Brain Mapping, Cerebral Cortex, Cerebrovascular Circulation, Cognition, Erythropoietin, Female, Frontal Lobe, Gyrus Cinguli, Humans, Magnetic Resonance Imaging, Male, Memory, Short-Term, Nerve Growth Factors, Nerve Net, Neuropsychological Tests, Parietal Lobe, Thinking, Time, Time Factors, Verbal Behavior, Cohort Studies, Treatment Outcome, Nootropic Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review